Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steeve Provencher

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Circulation|June 26, 2014
Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3pSalil Sharma, Soban Umar, Francois Potus, et al.
American Journal of Respiratory and Critical Care Medicine|February 16, 2023
Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy: A Prospective Multi-Centre Agreement Clinical Trial (CAN-ICE)Marc Fortin, Moishe Liberman, Antoine Delage, et al.
Journal of the American College of Cardiology|June 27, 2009
End points and clinical trial design in pulmonary arterial hypertensionVallerie V McLaughlin, David B Badesch, Marion Delcroix, et al.
Stroke|November 14, 2019
Journal Initiatives to Enhance Preclinical Research: Analyses of <i>Stroke, Nature Medicine, Science Translational Medicine</i>F Daniel Ramirez, Richard G Jung, Pouya Motazedian, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 17, 2019
Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial HypertensionAlice Bourgeois, Sébastien Bonnet, Sandra Breuils-Bonnet, et al.
Circulation Research|March 29, 2020
Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular FibrosisLian Tian, Danchen Wu, Asish Dasgupta, et al.
International Journal of Molecular Sciences|August 10, 2024
Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular FunctionJoana Santos-Gomes, Pedro Mendes-Ferreira, Rui Adão, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Pharmacological Inhibition of Epac1 Protects against Pulmonary Fibrosis by Blocking FoxO3a NeddylationKatherine Jankowski, Sarah E Lemay, Daniel Lozano-Ojalvo, et al.
Journal of the American Heart Association|March 26, 2013
Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiologyJolyane Meloche, Antony Courchesne, Marjorie Barrier, et al.
American Journal of Respiratory and Critical Care Medicine|February 3, 2018
Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial HypertensionOlivier Boucherat, Thibaut Peterlini, Alice Bourgeois, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Circulation|June 26, 2014
Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3pSalil Sharma, Soban Umar, Francois Potus, et al.
American Journal of Respiratory and Critical Care Medicine|February 16, 2023
Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy: A Prospective Multi-Centre Agreement Clinical Trial (CAN-ICE)Marc Fortin, Moishe Liberman, Antoine Delage, et al.
Journal of the American College of Cardiology|June 27, 2009
End points and clinical trial design in pulmonary arterial hypertensionVallerie V McLaughlin, David B Badesch, Marion Delcroix, et al.
Stroke|November 14, 2019
Journal Initiatives to Enhance Preclinical Research: Analyses of <i>Stroke, Nature Medicine, Science Translational Medicine</i>F Daniel Ramirez, Richard G Jung, Pouya Motazedian, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 17, 2019
Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial HypertensionAlice Bourgeois, Sébastien Bonnet, Sandra Breuils-Bonnet, et al.
Circulation Research|March 29, 2020
Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular FibrosisLian Tian, Danchen Wu, Asish Dasgupta, et al.
International Journal of Molecular Sciences|August 10, 2024
Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular FunctionJoana Santos-Gomes, Pedro Mendes-Ferreira, Rui Adão, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Pharmacological Inhibition of Epac1 Protects against Pulmonary Fibrosis by Blocking FoxO3a NeddylationKatherine Jankowski, Sarah E Lemay, Daniel Lozano-Ojalvo, et al.
Journal of the American Heart Association|March 26, 2013
Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiologyJolyane Meloche, Antony Courchesne, Marjorie Barrier, et al.
American Journal of Respiratory and Critical Care Medicine|February 3, 2018
Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial HypertensionOlivier Boucherat, Thibaut Peterlini, Alice Bourgeois, et al.
Pageof 17